OmniPulse Biosciences
Cambridge, US · Founded 2022 · 1 known investors
A biotech company developing a multi-layered polymer delivery system for sustained-release vaccine and medication administration via single injection.
Founders & leadership
OmniPulse Biosciences was founded in 2022 by Ana Jacklenec and Robert Farra.
AJ
Ana JacklenecCo-founder
RF
Robert FarraCo-founder
Board
DZ
David ZhuBoard director
FH
Felicia HsuBoard director
RL
Robert LangerBoard director
Investors · 1
Reported raises · per SEC filings
Form D private placements$7M disclosed across 1 round · 2023
▶$7MraisedJan 2024 · 2 investors · BiotechnologyRule 506(b)
▶$7MraisedJan 2024 · 2 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Ana JacklenecDirector, Promoter
- David ZhuDirector
- Robert FarraExecutive Officer, Director
- Joseph DeSimonePromoter
- Felicia HsuDirector
- Robert LangerDirector, Promoter
- Offering amount
- $12.5M
- Amount sold
- $7M
- Proceeds to insiders
- $1.4M
- First sale
- Dec 2023
- Incorporated
- Corporation, Delaware, 2022
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- What does OmniPulse Biosciences do?
- A biotech company developing a multi-layered polymer delivery system for sustained-release vaccine and medication administration via single injection.
- Who founded OmniPulse Biosciences?
- OmniPulse Biosciences was founded by Ana Jacklenec, Robert Farra in 2022.
- Who are OmniPulse Biosciences's investors?
- OmniPulse Biosciences's investors include Kendall Capital Partners.
- How much funding has OmniPulse Biosciences raised?
- OmniPulse Biosciences has disclosed $7M raised across 1 round.
- Where is OmniPulse Biosciences headquartered?
- OmniPulse Biosciences is headquartered in Cambridge, US.